These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4018423)

  • 1. Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy.
    Lauritzen T; Frost-Larsen K; Larsen HW; Deckert T
    Diabetes; 1985 Aug; 34 Suppl 3():74-9. PubMed ID: 4018423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics.
    Lauritzen T; Frost-Larsen K; Larsen HW; Deckert T
    Lancet; 1983 Jan; 1(8318):200-4. PubMed ID: 6130243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 6 months of strict metabolic control on eye and kidney function in insulin-dependent diabetics with background retinopathy. Steno study group.
    Lancet; 1982 Jan; 1(8264):121-4. PubMed ID: 6119509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of plasma glucose control by continuous subcutaneous insulin infusion or conventional therapy on retinal morphology and urinary albumin excretion.
    Bell PM; Hayes JR; Hadden DR; Archer DB
    Diabete Metab; 1985 Aug; 11(4):254-61. PubMed ID: 3899766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of insulin pump treatment for one year on renal function and retinal morphology in patients with IDDM.
    Beck-Nielsen H; Richelsen B; Mogensen CE; Olsen T; Ehlers N; Nielsen CB; Charles P
    Diabetes Care; 1985; 8(6):585-9. PubMed ID: 4075944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin pump treatment: effect on glucose homeostasis, metabolites, hormones, insulin antibodies and quality of life.
    Beck-Nielsen H; Richelsen B; Schwartz Sørensen N; Hother Nielsen O
    Diabetes Res; 1985 Jan; 2(1):37-43. PubMed ID: 3888495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of near normoglycemia for 5 years on progression of early diabetic retinopathy and renal involvement.
    Beck-Nielsen H; Olesen T; Mogensen CE; Richelsen B; Olsen HW; Ehlers N; Charles P; Sørensen NS
    Diabetes Res; 1990 Dec; 15(4):185-90. PubMed ID: 2132407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous insulin infusion therapy and retinopathy in patients with type I diabetes.
    Helve E; Laatikainen L; Merenmies L; Koivisto VA
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):313-9. PubMed ID: 3303785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic retinopathy after 3 years' treatment with continuous subcutaneous insulin infusion (CSII).
    Olsen T; Richelsen B; Ehlers N; Beck-Nielsen H
    Acta Ophthalmol (Copenh); 1987 Apr; 65(2):185-9. PubMed ID: 3300140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 36 months continuous subcutaneous insulin infusion (CSII) in insulin dependent diabetes (IDDM)--influence on early stages of retinopathy, nephropathy and neuropathy--psychological analysis.
    Bibergeil H; Hüttl I; Felsing W; Felsing U; Seidlein I; Herfurth S; Dabels J; Reichel G; Lüder C; Albrecht G
    Exp Clin Endocrinol; 1987 Aug; 90(1):51-61. PubMed ID: 3666060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study.
    Dahl-Jørgensen K; Brinchmann-Hansen O; Hanssen KF; Ganes T; Kierulf P; Smeland E; Sandvik L; Aagenaes O
    Br Med J (Clin Res Ed); 1986 Nov; 293(6556):1195-9. PubMed ID: 3096429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors for the development of diabetic retinopathy in patients with insulin-dependent diabetes mellitus treated with continuous subcutaneous insulin infusion].
    Austenat E
    Wien Med Wochenschr; 1992; 142(13):277-80. PubMed ID: 1413821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion.
    van Ballegooie E; Hooymans JM; Timmerman Z; Reitsma WD; Sluiter WJ; Schweitzer NM; Doorenbos H
    Diabetes Care; 1984; 7(3):236-42. PubMed ID: 6734393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion in the treatment of juvenile-onset diabetes.
    Buysschaert M; Lejeune M; Lambert AE
    Diabete Metab; 1981 Sep; 7(3):189-93. PubMed ID: 7319116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near-normoglycemia and late diabetic complications. The Oslo Study.
    Dahl-Jørgensen K
    Acta Endocrinol Suppl (Copenh); 1987; 284():1-38. PubMed ID: 3300128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline haemoglobin A1c influences retinal function after long-term insulin pump therapy.
    Klefter ON; Holfort SK; Larsen M
    Graefes Arch Clin Exp Ophthalmol; 2016 Mar; 254(3):467-73. PubMed ID: 26108526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion (Mill-Hill Infuser) versus multiple injections (Medi-Jector) in the treatment of insulin-dependent diabetes mellitus and the effect of metabolic control on microangiopathy.
    Chiasson JL; Ducros F; Poliquin-Hamet M; Lopez D; Lecavalier L; Hamet P
    Diabetes Care; 1984; 7(4):331-7. PubMed ID: 6381006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic retinopathy after one year of improved metabolic control obtained by continuous subcutaneous insulin infusion (CSII).
    Olsen T; Ehlers N; Nielsen CB; Beck-Nielsen H
    Acta Ophthalmol (Copenh); 1985 Jun; 63(3):315-9. PubMed ID: 4036563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macular recovery recorded by nyctometry in insulin-dependent diabetes mellitus.
    Frost-Larsen K
    Acta Ophthalmol Suppl (1985); 1991; (203):1-39. PubMed ID: 1667959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
    Olsen B; Johannesen J; Fredheim S; Svensson J;
    Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.